Systematic reviews and meta-analyses suggest modest benefits for glycaemic control and lipid profiles in people with type 2 diabetes or metabolic syndrome, but the overall quality of evidence is considered moderate at best
Once-weekly dosing improves adherence compared to daily oral medications, and sustained receptor activation produces consistent appetite suppression
Your monthly price does not change as your dose is titrated
Wegovy promotes weight loss and potentially other mechanisms not fully understood, which may improve liver inflammation and scarring, the FDA said in its approval notice
Nothing here is a dosing recommendation, a titration schedule, or administration guidance it is a summary of published trial findings and must not be used to guide personal use of any compound
Lately, health authorities have approved certain formulations of GLP-1 medicines, making them safe choices for people struggling with weight issues